CAPR

CAPR

USD

Capricor Therapeutics Inc. Common Stock

$6.060+0.005 (0.083%)

Real-time Price

Healthcare
Biotechnology
United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$6.055

High

$6.410

Low

$6.000

Volume

0.58M

Company Fundamentals

Market Cap

277.0M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

1.33M

Exchange

NCM

Currency

USD

52-Week Range

Low $5.68Current $6.060High $20.75

Related News

GlobeNewswire

Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel

–Publication highlights Deramiocel's anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development– SAN DIEGO, Nov. 03, 2025 (GLOBE

View more
Capricor Therapeutics Publishes Peer-Reviewed Study in Biomedicines Describing the Mechanism of Action and Potency Assay for its Investigational Cell Therapy, Deramiocel
GlobeNewswire

Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10

SAN DIEGO, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today

View more
Capricor Therapeutics to Present Third Quarter 2025 Financial Results and Recent Corporate Update on November 10
PR Newswire

Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm

Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Capricor Therapeutics, Inc. (NASDAQ:...

View more
Kuehn Law Encourages Investors of Capricor Therapeutics, Inc. to Contact Law Firm